161 related articles for article (PubMed ID: 10436786)
21. Genomic sequencing of DPC4 in the analysis of familial pancreatic carcinoma.
Moskaluk CA; Hruban RH; Schutte M; Lietman AS; Smyrk T; Fusaro L; Fusaro R; Lynch J; Yeo CJ; Jackson CE; Lynch HT; Kern SE
Diagn Mol Pathol; 1997 Apr; 6(2):85-90. PubMed ID: 9098646
[TBL] [Abstract][Full Text] [Related]
22. Transforming growth factor-beta responsiveness in DPC4/SMAD4-null cancer cells.
Dai JL; Schutte M; Bansal RK; Wilentz RE; Sugar AY; Kern SE
Mol Carcinog; 1999 Sep; 26(1):37-43. PubMed ID: 10487520
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of the tumor suppressor gene Smad4/DPC4 induces p21waf1 expression and growth inhibition in human carcinoma cells.
Hunt KK; Fleming JB; Abramian A; Zhang L; Evans DB; Chiao PJ
Cancer Res; 1998 Dec; 58(24):5656-61. PubMed ID: 9865717
[TBL] [Abstract][Full Text] [Related]
24. Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers.
Hilgers W; Song JJ; Haye M; Hruban RR; Kern SE; Fearon ER
Genes Chromosomes Cancer; 2000 Apr; 27(4):353-7. PubMed ID: 10719364
[TBL] [Abstract][Full Text] [Related]
25. ACVR1B (ALK4, activin receptor type 1B) gene mutations in pancreatic carcinoma.
Su GH; Bansal R; Murphy KM; Montgomery E; Yeo CJ; Hruban RH; Kern SE
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3254-7. PubMed ID: 11248065
[TBL] [Abstract][Full Text] [Related]
26. Molecular analyses of the 15q and 18q SMAD genes in pancreatic cancer.
Jonson T; Gorunova L; Dawiskiba S; Andrén-Sandberg A; Stenman G; ten Dijke P; Johansson B; Höglund M
Genes Chromosomes Cancer; 1999 Jan; 24(1):62-71. PubMed ID: 9892110
[TBL] [Abstract][Full Text] [Related]
27. Dpc4 transcriptional activation and dysfunction in cancer cells.
Dai JL; Turnacioglu KK; Schutte M; Sugar AY; Kern SE
Cancer Res; 1998 Oct; 58(20):4592-7. PubMed ID: 9788608
[TBL] [Abstract][Full Text] [Related]
28. Restoration of transforming growth factor Beta signaling by functional expression of smad4 induces anoikis.
Ramachandra M; Atencio I; Rahman A; Vaillancourt M; Zou A; Avanzini J; Wills K; Bookstein R; Shabram P
Cancer Res; 2002 Nov; 62(21):6045-51. PubMed ID: 12414627
[TBL] [Abstract][Full Text] [Related]
29. Higher frequency of DPC4/Smad4 alterations in pancreatic cancer cell lines than in primary pancreatic adenocarcinomas.
Bartsch D; Barth P; Bastian D; Ramaswamy A; Gerdes B; Chaloupka B; Deiss Y; Simon B; Schudy A
Cancer Lett; 1999 May; 139(1):43-9. PubMed ID: 10408907
[TBL] [Abstract][Full Text] [Related]
30. Analysis of SMAD4/DPC4 gene alterations in multiploid colorectal carcinomas.
Ando T; Sugai T; Habano W; Jiao YF; Suzuki K
J Gastroenterol; 2005 Jul; 40(7):708-15. PubMed ID: 16082587
[TBL] [Abstract][Full Text] [Related]
31. Loss of DPC4 expression and its correlation with clinicopathological parameters in pancreatic carcinoma.
Hua Z; Zhang YC; Hu XM; Jia ZG
World J Gastroenterol; 2003 Dec; 9(12):2764-7. PubMed ID: 14669329
[TBL] [Abstract][Full Text] [Related]
32. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
[TBL] [Abstract][Full Text] [Related]
33. [SMAD4/DPC4 (small mothers against decapentaplegic deleted in pancreatic carcinoma, locus 4). Tumor suppressor gene].
Bull Cancer; 1998 Oct; 85(10):832. PubMed ID: 9867367
[No Abstract] [Full Text] [Related]
34. High-throughput drug screening of the DPC4 tumor-suppressor pathway in human pancreatic cancer cells.
Sohn TA; Su GH; Ryu B; Yeo CJ; Kern SE
Ann Surg; 2001 May; 233(5):696-703. PubMed ID: 11323508
[TBL] [Abstract][Full Text] [Related]
35. Frequent loss of SMAD4/DPC4 protein in colorectal cancers.
Salovaara R; Roth S; Loukola A; Launonen V; Sistonen P; Avizienyte E; Kristo P; Järvinen H; Souchelnytskyi S; Sarlomo-Rikala M; Aaltonen LA
Gut; 2002 Jul; 51(1):56-9. PubMed ID: 12077092
[TBL] [Abstract][Full Text] [Related]
36. Role of Smad4 (DPC4) inactivation in human cancer.
Miyaki M; Kuroki T
Biochem Biophys Res Commun; 2003 Jul; 306(4):799-804. PubMed ID: 12821112
[TBL] [Abstract][Full Text] [Related]
37. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S
Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137
[TBL] [Abstract][Full Text] [Related]
38. Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis.
Imai Y; Kurokawa M; Izutsu K; Hangaishi A; Maki K; Ogawa S; Chiba S; Mitani K; Hirai H
Oncogene; 2001 Jan; 20(1):88-96. PubMed ID: 11244507
[TBL] [Abstract][Full Text] [Related]
39. SMAD4/DPC4 and pancreatic cancer survival. Commentary re: M. Tascilar et al., The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin. Cancer Res., 7: 4115-4121, 2001.
Liu F
Clin Cancer Res; 2001 Dec; 7(12):3853-6. PubMed ID: 11751474
[No Abstract] [Full Text] [Related]
40. TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines.
Fink SP; Mikkola D; Willson JK; Markowitz S
Oncogene; 2003 Mar; 22(9):1317-23. PubMed ID: 12618756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]